Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development.

Bégin-Lavallée V, Midavaine É, Dansereau MA, Tétreault P, Longpré JM, Jacobi AM, Rose SD, Behlke MA, Beaudet N, Sarret P.

Mol Pain. 2016 Jun 15;12. pii: 1744806916653969. doi: 10.1177/1744806916653969. Print 2016.

2.

Contribution of chemokine CCL2/CCR2 signaling in the dorsal root ganglion and spinal cord to the maintenance of neuropathic pain in a rat model of lumbar disc herniation.

Zhu X, Cao S, Zhu MD, Liu JQ, Chen JJ, Gao YJ.

J Pain. 2014 May;15(5):516-26. doi: 10.1016/j.jpain.2014.01.492. Epub 2014 Jan 23.

PMID:
24462503
3.

Central delivery of Dicer-substrate siRNA: a direct application for pain research.

Doré-Savard L, Roussy G, Dansereau MA, Collingwood MA, Lennox KA, Rose SD, Beaudet N, Behlke MA, Sarret P.

Mol Ther. 2008 Jul;16(7):1331-9. doi: 10.1038/mt.2008.98. Epub 2008 Jun 3.

4.

Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats.

Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, Mauborgne A, Rostene W, Kitabgi P, Beaudet N, Sarret P, Melik-Parsadaniantz S.

J Neurochem. 2008 Jul;106(2):757-69. doi: 10.1111/j.1471-4159.2008.05429.x. Epub 2008 Apr 17.

5.

NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9.

Kular L, Rivat C, Lelongt B, Calmel C, Laurent M, Pohl M, Kitabgi P, Melik-Parsadaniantz S, Martinerie C.

J Neuroinflammation. 2012 Feb 21;9:36. doi: 10.1186/1742-2094-9-36.

6.

Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses.

Menetski J, Mistry S, Lu M, Mudgett JS, Ransohoff RM, Demartino JA, Macintyre DE, Abbadie C.

Neuroscience. 2007 Nov 9;149(3):706-14. Epub 2007 Aug 14.

PMID:
17870246
7.

Force-dependent development of neuropathic central pain and time-related CCL2/CCR2 expression after graded spinal cord contusion injuries of the rat.

Knerlich-Lukoschus F, Juraschek M, Blömer U, Lucius R, Mehdorn HM, Held-Feindt J.

J Neurotrauma. 2008 May;25(5):427-48. doi: 10.1089/neu.2007.0431.

PMID:
18338959
8.

Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice.

Llorián-Salvador M, Pevida M, González-Rodríguez S, Lastra A, Fernández-García MT, Hidalgo A, Baamonde A, Menéndez L.

Fundam Clin Pharmacol. 2016 Jun;30(3):235-47. doi: 10.1111/fcp.12182. Epub 2016 Feb 17.

PMID:
26820818
9.

CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy.

Aye-Mon A, Hori K, Kozakai Y, Nakagawa T, Hiraga S, Nakamura T, Shiraishi Y, Okuda H, Ozaki N.

Mol Pain. 2018 Jan-Dec;14:1744806917751322. doi: 10.1177/1744806917751322.

10.

Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2.

Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7947-52. Epub 2003 Jun 13.

11.

Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia.

Pevida M, González-Rodríguez S, Lastra A, García-Suárez O, Hidalgo A, Menéndez L, Baamonde A.

Cell Mol Neurobiol. 2014 Jan;34(1):143-56.

PMID:
24122510
12.

Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones.

Gosselin RD, Varela C, Banisadr G, Mechighel P, Rostene W, Kitabgi P, Melik-Parsadaniantz S.

J Neurochem. 2005 Nov;95(4):1023-34. Epub 2005 Sep 7.

13.

The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.

Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Mika J.

J Neuroimmune Pharmacol. 2017 Sep;12(3):402-419. doi: 10.1007/s11481-017-9729-6. Epub 2017 Mar 23.

14.

Chemokine signaling involving chemokine (C-C motif) ligand 2 plays a role in descending pain facilitation.

Guo W, Wang H, Zou S, Dubner R, Ren K.

Neurosci Bull. 2012 Apr;28(2):193-207. doi: 10.1007/s12264-012-1218-6.

15.

CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury.

Van Steenwinckel J, Reaux-Le Goazigo A, Pommier B, Mauborgne A, Dansereau MA, Kitabgi P, Sarret P, Pohl M, Mélik Parsadaniantz S.

J Neurosci. 2011 Apr 13;31(15):5865-75. doi: 10.1523/JNEUROSCI.5986-10.2011.

16.

Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain.

Serrano A, Paré M, McIntosh F, Elmes SJ, Martino G, Jomphe C, Lessard E, Lembo PM, Vaillancourt F, Perkins MN, Cao CQ.

Mol Pain. 2010 Dec 10;6:90. doi: 10.1186/1744-8069-6-90.

17.

Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats.

Wang Y, Ni H, Li H, Deng H, Xu LS, Xu S, Zhen Y, Shen H, Pan H, Yao M.

Mol Pain. 2018 Jan-Dec;14:1744806918788681. doi: 10.1177/1744806918788681. Epub 2018 Jun 29.

18.

Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats.

Hu JH, Zheng XY, Yang JP, Wang LN, Ji FH.

Neurosci Lett. 2012 May 23;517(1):60-3. doi: 10.1016/j.neulet.2012.04.026. Epub 2012 Apr 15.

PMID:
22531750
19.

Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation.

Arms L, Girard BM, Malley SE, Vizzard MA.

Am J Physiol Renal Physiol. 2013 Jul 1;305(1):F111-22. doi: 10.1152/ajprenal.00139.2013. Epub 2013 Apr 17.

20.

Gene knockdown of the N-methyl-D-aspartate receptor NR1 subunit with subcutaneous small interfering RNA reduces inflammation-induced nociception in rats.

Tan PH, Chia YY, Chow LH, Chen JJ, Yang LC, Hung KC, Chen HS, Kuo CH.

Anesthesiology. 2010 Jun;112(6):1482-93. doi: 10.1097/ALN.0b013e3181d69494.

PMID:
20463582

Supplemental Content

Support Center